Splanchnic vein thrombosis and myeloproliferative neoplasms: molecular-driven diagnosis and long-term treatment.

Thrombosis and Haemostasis
Valerio De StefanoElena Rossi

Abstract

Splanchnic vein thrombosis (SVT) encompasses Budd-Chiari syndrome (BCS), extrahepatic portal vein obstruction (EHPVO), and mesenteric vein thrombosis. Philadelphia-negative myeloproliferative neoplasms (MPNS) are the leading systemic cause of non-cirrhotic and non-malignant SVT and are diagnosed in 40% of BCS patients and one-third of EHPVO patients. In SVT patients the molecular marker JAK2 V617F is detectable up to 87% of those with overt MPN and up to 26% of those without. In the latter, other MPN molecular markers, such as mutations in JAK2 exon 12, CALR and MPL genes, are extremely rare. Immediate anticoagulation with heparin is used to treat acute patients. Upon clinical deterioration, catheter-directed thrombolysis or a transjugular intrahepatic portosystemic shunt is used in conjunction with anticoagulation. Orthotopic liver transplantation is the only reliable option in BCS patients with a lack of a response to other treatments, without contraindication due to MPN. Long-term oral anticoagulation with vitamin K-antagonists (VKA) is recommended in all SVT patients with the MPN-related permanent prothrombotic state; the benefits of adding aspirin to VKA are uncertain. Cytoreduction is warranted in all SVT patients with an...Continue Reading

References

Apr 1, 1991·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·T P Almdal, T I Sørensen
Jul 1, 1999·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·G ZeitounD Valla
Mar 8, 2000·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·M H DenningerD Valla
Feb 15, 2003·Journal of Hepatology·Harry L A JanssenUNKNOWN European Group for the Study of Vascular Disorders of the Liver
Feb 10, 2004·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Sarwa Darwish MuradHarry L A Janssen
Jun 10, 2006·Liver International : Official Journal of the International Association for the Study of the Liver·Shiv Kumar SarinUNKNOWN Members of the APASL Working Party on Portal Hypertension
Nov 30, 2006·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Massimo PrimignaniPier Mannuccio Mannucci
Oct 26, 2007·The American Journal of Gastroenterology·Lucio AmitranoAntonio Balzano
Apr 9, 2008·Thrombosis and Haemostasis·Francesco DentaliWalter Ageno
Jul 16, 2008·Gastroenterology·Juan Carlos Garcia-PagánUNKNOWN Budd-Chiari Syndrome-Transjugular Intrahepatic Portosystemic Shunt Group
Aug 13, 2008·Liver International : Official Journal of the International Association for the Study of the Liver·Rupesh RajaniSven H C Almer
Aug 23, 2008·The British Journal of Surgery·S AcostaO Ekberg
Jan 10, 2009·Thrombosis and Haemostasis·Jasper H SmalbergFrank W G Leebeek
Mar 17, 2009·Nature Genetics·Amy V JonesNicholas C P Cross
Mar 17, 2009·Nature Genetics·Damla OlcayduRobert Kralovics
Mar 24, 2009·Journal of Hepatology·Ida MartinelliPier Mannuccio Mannucci
Apr 29, 2009·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Laurie D DeLeveUNKNOWN American Association for the Study Liver Diseases
Aug 5, 2009·Annals of Internal Medicine·Sarwa Darwish MuradUNKNOWN EN-Vie (European Network for Vascular Disorders of the Liver)
Sep 29, 2009·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Mallikarjun R ThatipelliWaldemar E Wysokinski
Oct 13, 2009·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Aurelie PlessierUNKNOWN European Network for Vascular Disorders of the Liver (EN-Vie)
Oct 28, 2009·World Journal of Gastroenterology : WJG·Feng-Yong LiuPeng Song
May 26, 2010·Alimentary Pharmacology & Therapeutics·M C W SpaanderH L A Janssen
Jun 10, 2010·Internal and Emergency Medicine·Valerio De Stefano, Ida Martinelli
Jan 6, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Tiziano BarbuiUNKNOWN European LeukemiaNet
Mar 3, 2011·Blood·Jasper H SmalbergUNKNOWN European Network for Vascular Disorders of the Liver (EN-Vie)
May 20, 2011·American Journal of Hematology·Valerio De StefanoPatrizia Chiusolo

❮ Previous
Next ❯

Citations

Nov 23, 2016·Current Opinion in Hematology·Tiziano Barbui, Valerio De Stefano
Nov 24, 2016·American Journal of Hematology·Lisa PieriAlessandro M Vannucchi
Jan 13, 2017·European Journal of Internal Medicine·Mohammad Haris, Jecko Thachil
Mar 27, 2018·Expert Review of Anticancer Therapy·Eran ZimranMarina Kremyanskaya
Jul 10, 2018·Journal of Translational Internal Medicine·Stephen E Langabeer
Mar 9, 2019·Annals of Hematology·Martin GriesshammerCarlos Besses
Nov 14, 2019·American Journal of Hematology·Emanuela Sant'AntonioAlessandro Maria Vannucchi
Mar 14, 2020·Journal of Clinical Medicine·Nicoletta Riva, Walter Ageno
Aug 8, 2019·Insights Into Imaging·Sheng Fei OonJoseph Paiva
Apr 16, 2018·The Journal of Clinical Hypertension·Kouichi TamuraHiromichi Wakui
Jul 22, 2018·Wiener klinische Wochenschrift·Sonja BurgstallerHeinz Gisslinger
Jun 28, 2018·Blood Cancer Journal·Guido FinazziTiziano Barbui
Jan 3, 2020·The American Journal of Gastroenterology·Douglas A SimonettoPatrick S Kamath
Jan 4, 2020·Journal of Thrombosis and Thrombolysis·Fernanda Salles SeguroVanderson Rocha
Jun 12, 2021·Seminars in Thrombosis and Hemostasis·Omri CohenWalter Ageno
Dec 11, 2021·Hematology·Carol Mathew, Marc Zumberg

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

© 2021 Meta ULC. All rights reserved